Halozyme Therapeutics (HALO) Surpasses Q1 Earnings and Revenue Estimates

• click to rate

  Posted by Two Blokes May 6 - Filed in Stock - 4 views
  
  Halozyme Therapeutics (HALO) came out with quarterly earnings of $1.11 per share, beating the Zacks Consensus Estimate of $0.95 per share. This compares to earnings of $0.79 per share a year ago.